Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...

GSK's findings support the progression of the ... CureVac, established in 2000, has been a pioneer in mRNA technology, contributing significantly to the development of mRNA vaccines, including ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn ...

Moderna jolted investors by pushing back its profitability forecast two years, to 2028, and announcing a $1.1 billion cut in R&D spending.

The notice relates to non-deduction of TDS on payment of Rs 3,045 crore to GlaxoSmithKline Consumer Healthcare (GSKCH) for the acquisition of Intellectual Property Rights of the Health Foods ...

Bettersize Instruments, a leading manufacturer of particle analysis instrumentation, will host an informative webinar on ...

This partnership marks the 12th collaboration for RHEA Generics, with Bayer Philippines joining the roster of PHILUSA ...

If automation is to become a key partner in experiment design and a core component of modern lab infrastructure, it is ...

Data from each facility, experiment, instrument, and user is standardized and transferred to the data lake upon execution.

Invenra Inc. is pleased to announce the addition of three distinguished professionals to its Board of Directors: Saira Ramasastry, Heather Preston, MD, and William Hinshaw. Together, these leaders ...

Alume Biosciences is pleased to announce the appointment of Rick Gonzalez as Chief Commercial Officer. With over three decades of experience in the pharmaceutical industry, Mr. Gonzalez is a seasoned ...

August 27, 2024--(BUSINESS WIRE)--Today, Cerebras Systems, the pioneer in high performance ... SVP of AI/ML at GlaxoSmithKline, an early Cerebras customer.